Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogen

Journal of Investigative Dermatology

Volumn 128, Issue 8, 2008, Pages 2092-2101

  Green, Kirsty A ^a   Almholt, Kasper ^a   Ploug, Michael ^a   Rønø, Birgitte ^a   Castellino, Francis J ^b   Johnsen, Morten ^c   Bugge, Thomas H ^d   Rømer, John ^a   Lund, Leif R ^a,e  

^a FINSEN LABORATORY   (Denmark)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^e Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; ILOMASTAT; METALLOPROTEINASE; PLASMINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FIBRINOLYSIS; IN VIVO STUDY; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SKIN INJURY; WOUND HEALING;

EID: 47349128164     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.54     Document Type: Article

References (40)

1. Bezerra JA, Bugge TH, Melin-Aldana H, Sabla G, Kombrinck KW, Witte DP et al. (1999) Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver. Proc Natl Acad Sci USA 96:15143-8
2. Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Dano K et al. (1996a) Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci USA 93:5899-904
3. Bugge TH, Flick MJ, Daugherty CC, Degen JL (1995) Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9:794-807
4. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL (1996b) Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87:709-19
5. Bugge TH, Lund LR, Kombrinck KK, Nielsen BS, Holmback K, Drew AF et al. (1998) Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice. Oncogene 16:3097-104
6. Collen D, Lijnen HR (2005) Thrombolytic agents. Thromb Haemost 93:627-30
7. Coussens LM, Tinkle CL, Hanahan D, Werb Z (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-90
8. Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266
9. Danø K, Romer J, Nielsen BS, Bjørn S, Pyke C, Rygaard J et al. (1999) Cancer invasion and tissue remodeling - cooperation of protease systems and cell types. APMIS 107:120-7
10. Drew AF, Kaufman AH, Kombrinck KW, Danton MJ, Daugherty CC, Degen JL et al. (1998) Ligneous conjunctivitis in plasminogen-deficient mice. Blood 91:1616-24
11. Drew AF, Liu H, Davidson JM, Daugherty CC, Degen JL (2001) Wound-healing defects in mice lacking fibrinogen. Blood 97:3691-8
12. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-74
13. Grobelny D, Poncz L, Galardy RE (1992) Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry 31:7152-4
14. Gross TJ, Leavell KJ, Peterson MW (1997) CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain. Thromb Haemost 77:894-900
15. Grøndahl-Hansen J, Lund LR, Ralfkiaer E, Ottevanger V, Danø K (1988) Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J Invest Dermatol 90:790-5
16. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ (1998) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95:365-77
17. Hotary KB, Yana I, Sabeh F, Li XY, Holmbeck K, Birkedal-Hansen H et al. (2002) Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J Exp Med 195:295-308
18. Kemler R, Brulet P, Schnebelen MT, Gaillard J, Jacob F (1981) Reactivity of monoclonal antibodies against intermediate filament proteins during embryonic development. J Embryol Exp Morphol 64:45-60
19. Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J (1993) Expression of integrins and basement component by wound kerationocytes. J Clin Invest 92:1425-35
20. Laurens N, Koolwijk P, De Maat MP (2007) Fibrin structure and wound healing. J Thromb Haemost 4:932-9
21. Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X et al. (1998) Matrix metalloproteinase inhibitors: a structure-activity study. J Med Chem 41:199-223
22. Lijnen HR, Van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D (1998) Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 18:1035-45
23. Lund LR, Bjørn SF, Sternlicht MD, Nielsen BS, Solberg H, Usher PA et al. (2000) Lactational competence and involution of the mouse mammary gland require plasminogen. Development 127:4481-92
24. Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, Lilla J et al. (2006) Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J 25:2686-97
25. Lund LR, Rømer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL et al. (1999) Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 18:4645-56
26. Madlener M, Parks WC, Werner S (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 242:201-10
27. Mingers AM, Heimburger N, Zeitler P, Kreth HW, Schuster V (1997) Homozygous type I plasminogen deficiency. Semin Thromb Hemost 23:259-69
28. Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221-33
29. Ploplis VA, Wilberding J, McLennan L, Liang Z, Cornelissen I, DeFord ME et al. (2000) A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice. Am J Pathol 157:703-8
30. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C (2003) Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 4:544-58
31. Pyke C, Rømer J, Kallunki P, Lund LR, Ralfkiær E, Danø K et al. (1994) The gamma 2 chain of kalinin/laminin5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 145:782-91
32. Richardson DL, Pepper DS, Kay AB (1976) Chemotaxis for human monocytes by fibrinogen-derived peptides. Br J Haematol 32:507-13
33. Rømer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL et al. (1996) Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 2:287-92
34. Rømer J, Lund LR, Eriksen J, Pyke C, Kristensen P, Danø K (1994) The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol 102:519-22
35. Rømer J, Lund LR, Eriksen J, Ralfkiaer E, Zeheb R, Gelehrter TD et al. (1991) Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J Invest Dermatol 97:803-11
36. Saghatelian A, Jessani N, Joseph A, Humphrey M, Cravatt BF (2004) Activity-based probes for the proteomic profiling of metalloproteases. Proc Natl Acad Sci USA 101:10000-5
37. Schuster V, Mingers AM, Seidenspinner S, Nussgens Z, Pukrop T, Kreth HW (1997) Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. Blood 90:958-66
38. Selvarajan S, Lund LR, Takeuchi T, Craik CS, Werb Z (2001) A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol 3:267-75
39. Solberg H, Rinkenberger J, Danø K, Werb Z, Lund LR (2003) A functional overlap of plasminogen and MMPs regulates vascularization during placental development. Development 130:4439-50
40. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB et al. (1987) Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 84:5788-92